Dyslipidaemia Treat to Target Fam Med Dr Muller May 2022

Current international guidelines are rigorous in its approach to treat to target for dyslipidaemia. In this short summary we describe how this approach works - setting your target and determining treatment needed to reach that target. Note that in the current EML review this approach has not been sanctioned in public sector due to the cost implications. At the moment we cannot yet afford to use treat to target for each client.
The Family Medicine Treat to Target Summary series are short NDOH guideline based overviews of the important aspects of diagnosis, treatment steps and monitoring of patients with specific chronic conditions.